Abstract
The aim of the present work was to examine ellagic acid hydroxypropyl-β-cyclodextrin complex (EA-HP-β-CD) obtained through the freeze-drying method via FTIR, XRD, SEM, NMR and molecular modeling, as well as to investigate it’s antioxidant and anti-inflammatory activity on carrageenan-induced paw oedema in rats. Phase-solubility study showed that ellagic acid (EA) formed 1:2 stoichiometric inclusion complex with hydroxypropyl-β-cyclodextrin (HP-β-CD). The XRD and SEM analysis were confirmed true inclusion complex formation of EA with HP-β-CD by freeze-drying method when compared with a physical mixture. The FTIR, NMR and molecular modeling studies suggested that the carbonyl groups and hydroxyl groups of EA were involved in the inclusion complexation with HP-β-CD. EA-HP-β-CD exhibited better protection from protein denaturation and lysis of erythrocyte membrane as compared to positive controls. In vivo anti-inflammatory evaluation of EA-HP-β-CD in rats showed significant anti-inflammatory and antioxidant activity on carrageenan-induced rat paw oedema. The present findings suggest that EA-HP-β-CD inclusion complex enhances the anti-inflammatory and antioxidant effect of EA in experimental animal models.
Similar content being viewed by others
References
Ma, Q., Kinneer, K., Ye, J., Chen, B.J.: Inhibition of nuclear factor kappaB by phenolic antioxidants: interplay between antioxidant signaling and inflammatory cytokine expression. Mol. Pharmacol. 64, 211–219 (2003)
Landete, J.M.: Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health. Food Res. Int. 44, 1150–1160 (2011)
Grasser, G.: Synthetic Tannins. Enna F. G. A. (trans.) (3rd ed.) p. 20, London (1922)
Seeram, N.P., Lee, R., Heber, D.: Bio availability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin. Chim. Acta 348, 63–68 (2004)
Sonaje, K., Italia, J.L., Sharma, G., Bhardwaj, V., Tikoo, K., Ravi Kumar, M.N.V.: Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats. Pharm. Res. 24, 899–908 (2007)
Brewster, M.E., Loftsson, T.: Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 59, 645–666 (2007)
Fang, Z., Bhandari, B.: Encapsulation of polyphenols: a review. Trends Food Sci. Technol. 21, 510–523 (2010)
Kfoury, M., Auezova, L., Fourmentin, S., Greige-Gerges, H.: Investigation of monoterpenes complexation with hydroxypropyl-β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 80, 51–60 (2014)
Gould, S., Scott, R.C.: 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): a toxicology review. Food Chem. Toxicol. 43, 1451–1459 (2005)
Boukharta, M., Jalbert, G., Castonguay, A.: Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. Nutr. Cancer 18, 181–189 (1992)
Chudasama, Y.N., Lugea, A., Lu, Q.Y., Pandol, S.J.: Beta-cyclodextrin increases bioavailability of ellagic acid in rats. Gastroenterology 140, S-860 (2011)
Bulani, V., Kothavade, P., Nagmoti, D., Juvekar, A.: Ellagic acid hydroxypropyl-ß-cyclodextrin inclusion complex alleviates adjuvant-induced arthritis: attenuation of oxidative stress and inflammatory mediators. Cytokines 70, 32 (2014)
Higuchi, T., Connors, K.A.: Phase solubility techniques. In: Reiley, C.N. (ed.) Advance in Analytical Chemistry and Instrumentation, pp. 117–212. Wiley, New York (1965)
Maestro version 9.4, Schrödinger, LLC, New York, NY (2013)
MacroModel version 10.0, Schrödinger, LLC, New York, NY (2013)
Impact version 5.9, Schrödinger, LLC, New York, NY (2013)
Desmond version 3.4, D. E. Shaw Research, New York, NY (2013)
Manohara Reddy, S.A., Mudgal, J., Bansal, P., Vasanthraju, S.G., Srinivasan, K.K., Rao, C.M., Gopalan Kutty, N.: Antioxidant, anti-inflammatory and anti-hyperglycaemic activities of heterocyclic homoprostanoid derivatives. Bioorg. Med. Chem. 19, 384–392 (2011)
Shinde, U.A., Phadke, A.S., Nair, A.M., Mungantiwar, A.A., Dikshit, V.J., Saraf, M.N.: Membrane stabilizing activity—a possible mechanism of action for the anti-inflammatory activity of Cedrus deodara wood oil. Fitoterapia 70, 251–257 (1999)
Winter, C.A., Risley, E.A., Nuss, G.W.: Anti-Inflammatory and antipyretic activities of indomethacin, 1-(P-Chlorobenzoyl)-5-Methoxy-2-Methylindole-3-Acetic Acid. J. Pharmacol. Exp. Ther. 141, 369–376 (1963)
Anderson, A.J.: Lysosomal enzyme activity in rats with adjuvant-induced arthritis. Ann. Rheum. Dis. 29, 307–313 (1970)
Misra, H.P., Fridovich, I.: The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247, 3170–3175 (1972)
Aebi, H.: Catalase in vitro. In: Packer, L. (ed.) Methods in Enzymology, pp. 121–126. Academic Press, New York (1984)
Sedlak, J., Lindsay, R.H.: Estimation of total, protein bound and non protein sulfhydryl groups in tissue with Ellman’s reagent. Anal. Biochem. 25, 192–205 (1968)
Bradley, P.P., Priebat, D.A., Christensen, R.D., Rothstein, G.: Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78, 206–209 (1982)
Dandawate, P.R., Vyas, A., Ahmad, A., Banerjee, S., Deshpande, J., Swamy, K.V., Jamadar, A., Dumhe-Klaire, A.C., Padhye, S., Sarkar, F.H.: Inclusion complex of novel curcumin analogue CDF and β-Cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer. Pharm. Res. 29, 1775–1786 (2012)
Goriparti, S., Harish, M.N.K., Sampath, S.: Ellagic acid: a novel organic electrode material for high capacity lithium ion batteries. Chem. Commun. 49, 7234–7236 (2013)
Kim, S., Liu, Y., Gaber, M.W., Bumgardner, J.D., Haggard, W.O., Yang, Y.: Development of chitosan-ellagic acid films as a local drug delivery system to induce apoptotic death of human melanoma cells. J. Biomed. Mater. Res. B Appl. Biomater. 90, 145–155 (2009)
Zhang, Y., Ren, K., He, Z., Li, H., Chen, T., Lei, Y., Xiad, S., Hea, G., Xiea, Y., Zhenga, Y., Song, X.: Development of inclusion complex of brinzolamide with hydroxypropyl-β-cyclodextrin. Carbohydr. Polym. 98, 638–643 (2013)
Li, X.C., Elsohly, H.N., Hufford, C.D., Clark, A.M.: NMR assignments of ellagic acid derivatives. Magn. Reson. Chem. 37, 856–859 (1999)
Qiu, N., Cheng, X., Wang, G., Wang, W., Wen, J., Zhang, Y., Song, H., Ma, L., Wei, Y., Peng, A., Chen, L.: Inclusion complex of barbigerone with hydroxypropyl-β-cyclodextrin: preparation and in vitro evaluation. Carbohydr. Polym. 101, 623–630 (2014)
de Araujo, D.R., Tsuneda, S.S., Cereda, C.M.S., Carvalho, F.D.G.F., Prete, P.S.C., Fernandes, S.A., Fabiano, Y., Franco, M.K.K.D., Mazzaro, I., Fraceto, L.F., de Braga, F.A., de Paula, E.: Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex. Eur. J. Pharm. Sci. 33, 60–71 (2008)
Li, N., Zhang, Y.H., Wu, Y.N., Xiong, X.L., Zhang, Y.H.: Inclusion complex of trimethoprim with beta-cyclodextrin. J. Pharm. Biomed. Anal. 39, 824–829 (2005)
Reddy, M.N., Rehana, T., Ramakrishna, S., Chowdary, K.P.R., Diwan, P.V.: Beta-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies. AAPS J. 6, 68–76 (2004)
Jadhav, G.S., Vavia, P.R.: Physicochemical, in silico and in vivo evaluation of a danazol-β-cyclodextrin complex. Int. J. Pharm. 352, 5–16 (2008)
Kumari, K.D.K.P., Weerakoon, T.C.S., Handunnetti, S.M., Samarasinghe, K., Suresh, T.S.: Anti-inflammatory activity of dried flower extracts of Aegle marmelos in Wistar rats. J. Ethnopharmacol. 151, 1202–1208 (2014)
Lee, J., Kim, S., Namgung, H., Jo, Y.H., Bao, C., Choi, H.K., Auh, J.H., Lee, H.J.: Ellagic acid identified through metabolomic analysis is an active metabolite in Strawberry (‘Seolhyang’) regulating lipopolysaccharide-induced inflammation. J. Agric. Food Chem. 62, 3954–3962 (2013)
Corbett, S., Daniel, J., Drayton, R., Field, M., Steinhardt, R., Garrett, N.: Evaluation of the anti-inflammatory effects of ellagic acid. J. PeriAnesthesia Nurs. 25, 214–220 (2010)
Halici, Z., Dengiz, G.O., Odabasoglu, F., Suleyman, H., Cadirci, E., Halici, M.: Amiodarone has anti-inflammatory and anti-oxidative properties: an experimental study in rats with carrageenan-induced paw oedema. Eur. J. Pharmacol. 566, 215–221 (2007)
Cuzzocrea, S., Salvemini, D.: The role of superoxide in acute and chronic inflammation. In Therapeutic Application of Superoxide Dismutase (SOD), Landes Bioscience, Georgetown, Texas, USA (Chapter 3) (2005)
Afonso, V., Champy, R., Mitrovic, D., Collin, P., Lomri, A.: Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine 74, 324–329 (2007)
Mittal, M., Siddiqui, M.R., Tran, K., Reddy, S.P., Malik, A.B.: Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 20, 1126–1167 (2014)
Chaturvedi, P.: Inhibitory response of Raphanus sativus on lipid peroxidation in albino rats. Evid. Based Complement. Altern. Med. 5, 55–59 (2008)
Mo, J., Panichayupakaranant, P., Kaewnopparat, N., Songkro, S., Reanmongkol, W.: Topical anti-inflammatory potential of standardized pomegranate rind extract and ellagic acid in contact dermatitis. Phytother. Res. 28, 629–632 (2014)
Han, D.H., Lee, M.J., Kim, J.H.: Antioxidant and apoptosis-inducing activities of ellagic acid. Anticancer Res. 26, 3601–3606 (2006)
Acknowledgements
Authors are thankful to the University Grant Commission, India (UGC) for the research fellowship awarded under special assistance programme (SAP) and Sophisticated Analytical Instrument Facility, Indian Institute of Technology, Madras, India, for spectral analysis.
Conflict of interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bulani, V.D., Kothavade, P.S., Nagmoti, D.M. et al. Characterisation and anti-inflammatory evaluation of the inclusion complex of ellagic acid with hydroxypropyl-β-cyclodextrin. J Incl Phenom Macrocycl Chem 82, 361–372 (2015). https://doi.org/10.1007/s10847-015-0498-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-015-0498-7